Results 141 to 150 of about 63,430 (242)

Safety and Efficacy of the NMDA‐2b‐Selective Negative Allosteric Modulator BI 1569912: A Phase Ib Randomized Trial in Major Depressive Disorder

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Selective N‐methyl‐D‐aspartate receptor subunit 2b negative allosteric modulators (NR2B NAMs) are being explored as potential new treatment options for major depressive disorder (MDD). This Phase Ib, randomized, double‐blind, placebo‐controlled, parallel‐group trial was conducted in adults (N = 59) with moderate‐to‐severe MDD and insufficient response ...
Roger S. McIntyre   +9 more
wiley   +1 more source

Deciphering the allosteric regulation of mycobacterial inosine-5'-monophosphate dehydrogenase. [PDF]

open access: yesNat Commun
Bulvas O   +8 more
europepmc   +1 more source

Differential regulation of muscarinic M1 receptors by orthosteric and allosteric ligands [PDF]

open access: hybrid, 2009
Christopher N. Davis   +7 more
openalex   +1 more source

Allosteric regulation in drug design [PDF]

open access: yesCurrent Trends in Biomedical Engineering & Biosciences, 2017
openaire   +2 more sources

Cannabidiol Lacks Direct Effect on Cortical Excitability: A Randomized, Double Blind, Placebo Controlled, 3‐Way Crossover Trial

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Cannabidiol (CBD) is approved as an adjunctive treatment of seizures associated with Dravet syndrome, Lennox–Gastaut Syndrome, and tuberous sclerosis. Its therapeutic and adverse effects are thought to arise, at least partly, from a pharmacokinetic interaction with clobazam, another anti‐seizure medication (ASM).
Andriy A. Gorbenko   +7 more
wiley   +1 more source

Structural basis for allosteric regulation of human phosphofructokinase-1. [PDF]

open access: yesNat Commun
Lynch EM   +6 more
europepmc   +1 more source

Cis-Allosteric Regulation of HIV-1 Reverse Transcriptase by Integrase. [PDF]

open access: yesViruses, 2022
Masuda T   +5 more
europepmc   +1 more source

Identification and Investigation of the Intrinsic Receptor Activation Potential and Metabolization of the New Oxo‐Pyridyl Synthetic Cannabinoid Receptor Agonist CH‐FUBBMPDORA

open access: yesDrug Testing and Analysis, EarlyView.
Another Chinese generic ban‐evading SCRA, CH‐FUBBMPDORA, has emerged. This study reports its first identification in Europe, its analytical characterization (NMR, Raman, FTIR, GC–MS, and HRMS), its cannabinoid activation potential in a βarr2 recruitment assay, and its metabolization profile.
Marie H. Deventer   +13 more
wiley   +1 more source

A short intrinsically disordered region at KtrB's N-terminus facilitates allosteric regulation of K<sup>+</sup> channel KtrAB. [PDF]

open access: yesNat Commun
Stautz J   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy